ABSTRACT 2019 coronavirus disease (COVID-19) is a disease caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2). In addition to respiratory illness, COVID …

The edible cyanobacterium Spirulina platensis and its chief biliprotein C-Phycocyanin have
shown protective activity in animal models of diverse human health diseases, often reflecting …

It has been more than three years since COVID-19 impacted the lives of millions of people,
many of whom suffer from long-term effects known as long-haulers. Notwithstanding …

Since 2003, the world has been confronted with three new betacoronaviruses that cause
human respiratory infections: SARS-CoV, which causes severe acute respiratory syndrome …

Patients with severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) infection
manifest mainly respiratory symptoms. However, clinical observations frequently identified …

In the current pandemic, scenario the world is facing a huge shortage of effective drugs and
other prophylactic medicine to treat patients which created havoc in several countries with …

Although COVID-19 largely causes respiratory complications, it can also lead to various
extrapulmonary manifestations resulting in higher mortality and these comorbidities are …

COVID-19 has represented an issue for global health since its outbreak in March 2020. It is
now evident that the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …

Traditional cell lines and xenograft models have been widely recognized and used in
research. As a new research model, organoids have made significant progress and …

Pathogenesis of viral infections of the central nervous system (CNS) is poorly understood,
and this is partly due to the limitations of currently used preclinical models. Brain organoid …